Aaron Cowen’s Pfizer PFE Stock Holding History

Aaron Cowen’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-864,280	Closed	-$24.3M	–	32
2016 Q1	$24.3M	Buy	+864,280	New	+$24.7M	0.92%	21

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Aaron Cowen's PFE Position: Q1 2024 in Review

Aaron Cowen sold out of Pfizer (PFE) in Q1 2024, closing a stake of 50,300 shares — an estimated $1.45M sold.

Aaron Cowen first reported a position in PFE in Q3 2015 and held it in 7 quarters. The position peaked at $189M in Q1 2016. 2,878 funds tracked by Wall St. Rank hold PFE as of Q1 2024.

Aaron Cowen reported no remaining Pfizer position as of Q1 2024 after selling out during the quarter.
Aaron Cowen sold 50,300 Pfizer shares in Q1 2024, an estimated $1.45M.
Aaron Cowen first reported a position in Pfizer in Q3 2015 and held it in 7 quarters.
Aaron Cowen's Pfizer position peaked at $189M in Q1 2016.
2,878 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.

Based on Suvretta Capital Management's 13F filing for Q1 2024, filed 15 May 2024.